Posted by Michael Wonder on 29 Aug 2016
US health care system begins to embrace cost effectiveness as a central component of "value'
29 August 2016 - Value in Health series indicates the US may have reached a tipping point.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a series of articles suggesting that the application of cost-effectiveness analysis for health care decision making in the US may be approaching critical mass. This special themed section, Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?, was published in the July/August 2016 in Value in Health. The guest editor for the themed section is Lou Garrison, PhD, University of Washington, Seattle, WA, USA.
